AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| MAX GOLDMAN | — |
| HALLIE KOCH | — |
| KELLY MCCONE New | — |
Medicare/Medicaid MMM
S. 368/ H.R. 1332: Telehealth Modernization Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 H.R. 3173: Improving Seniors Timely Access to Care Act H.R.8800 - Supporting Medicare Providers Act of 2022 H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with changes finalized in the 2022 Medicare Physician Fee Schedule redefining the substantive portion of a split (or shared) visit starting in 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| MAX GOLDMAN | — |
| HALLIE KOCH | — |
Veterans VET
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| HALLIE KOCH | — |
Insurance INS
S. 464/ H.R. 2163: Safe Step Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| MAX GOLDMAN | — |
| HALLIE KOCH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.